← All Sponsors
SPONSOR

Nanjing Zenshine Pharmaceuticals

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Advanced Solid Tumors
NCT07310134 Phase 1
Recruiting

Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ZX-8177 in Patients With Advanced Solid Tumors

Advanced Solid Tumors
China View Trial →